Remove 2010 Remove Brands Remove Licensing Remove Public Use
article thumbnail

Biosimilars 2020 Year in Review

Fish & Richardson Trademark & Copyright Thoughts

For the first time since FDA licensed the first biosimilar, Sandoz’s Zarxio ® (filgrastim-sndz), in 2015, the United States saw a decrease in annual biosimilar approvals in 2020. BI argues that FDA’s current interpretation “encourages, or at least permits, brand sponsors to use minor concentration changes as an anti-competitive tactic.”

article thumbnail

Intellectual Property Tools for Protecting Fashion Goods

LexBlog IP

Fashion companies should be aware that they may need to obtain a license to, or ownership of, the copyright from the photographer. A novel design is entitled to a patent unless it is has been (1) described in a printed publication; (2) in public use; or (3) on sale more than one year prior to the date of the application of the patent. [9].

article thumbnail

Intellectual Property Tools for Protecting Fashion Goods

Above the Fold

Fashion companies should be aware that they may need to obtain a license to, or ownership of, the copyright from the photographer. A novel design is entitled to a patent unless it is has been (1) described in a printed publication; (2) in public use; or (3) on sale more than one year prior to the date of the application of the patent. [9].